Back to all discussions

lymphotoxin beta receptor blockers for COPD

“Our idea is to develop lymphotoxin beta receptor blockers for COPD which reduce lung epithelial cell death and lung inflammation. The automatic activation of Wnt signaling could then induce lung tissue regeneration,” Yildirim said.

“One of the biggest issues in COPD is that the lung cannot regenerate itself,” he added. “Therefore, a treatment that cures the disease needs to focus on lung tissue regeneration and blocking of lung epithelial cell death.”
This is what I call meaningful research.

  1. Thank you for the insights, love your post.

    1. LOve this, thanks for putting some insights like this. Appreciate you!

      or create an account to reply.